BUDGET IMPACT ANALYSIS OF THE USE OF ASPART INSULIN DURING HOSPITALIZATION OF PATIENTS WITH HYPERGLYCAEMIA IN ITALY

被引：0
|
作者：
Iannazzo, S. [1 ]
Pradelli, L. [1 ]
Montagnoli, R. [2 ]
Militano, L. [2 ]
机构：
[1] AdRes HE&OR, Turin, Italy
[2] Novo Nordisk Farmaceut Spa, Rome, Italy
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.1327
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A475 / A476
页数：2
相关论文
共 50 条
  • [1] BUDGET IMPACT ANALYSIS OF THE USE OF LURASIDONE IN PATIENTS WITH SCHIZOPHRENIA IN ITALY
    D'Ambrosio, F.
    Bini, C.
    Marcellusi, A.
    Mennini, F. S.
    VALUE IN HEALTH, 2018, 21 : S248 - S248
  • [2] Clinical impact of biphasic insulin aspart on hyperglycaemia and dystipidaemia in type 2 diabetes
    Lalic, Nebojsa M.
    Micic, D.
    Antic, S.
    Bajovic, L.
    Pantelinac, P.
    Jotic, A.
    Kendereski, A.
    Dimic, D.
    Djukic, A.
    Mitrovic, M.
    Vujasin, M.
    DIABETES, 2006, 55 : A469 - A469
  • [3] Randomized-controlled study of isophane and aspart insulin versus glargine and aspart insulin to treat prednisolone-induced hyperglycaemia in hospitalized patients
    Radhakutty, Anjana
    Stranks, Jessica L.
    Mangelsdorf, Brenda L.
    Drake, Sophie M.
    Roberts, Gregory W.
    Zimmermann, Anthony
    Stranks, Stephen N.
    Thompson, Campbell H.
    Burt, Morton G.
    CLINICAL ENDOCRINOLOGY, 2017, 86 : 22 - 22
  • [4] Budget impact analysis of different rapid-acting insulin analogues in Italy
    Lanati, Elena P.
    La Malfa, Paola
    Iorio, Arianna
    Mennini, Francesco S.
    Fanelli, Francesca
    Gentile, Sandro
    GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT, 2018,
  • [5] Budget impact analysis of the use of rituximab in the treatment of rheumatoid arthritis in Italy
    Benucci, Maurizio
    Iannazzo, Sergio
    Sabadini, Luciano
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2009, 10 (01) : 19 - 31
  • [6] Biphasic insulin aspart 30 treatment for people with type 2 diabetes: a budget impact analysis based in Thailand
    Deerochanawong, Chaicharn
    Kosachunhanun, Natapong
    Chotikanokrat, Pitthaporn
    Permsuwan, Unchalee
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (02) : 369 - 375
  • [7] Budget impact analysis of the use of lapatinib in the treatment of breast cancer in Italy
    Bamfi, Francesco
    Basso, Federica
    Aglietta, Massimo
    Bengala, Carmelo
    Lorusso, Vito
    Pronzato, Paolo
    Cavallo, Maria Caterina
    Zaniolo, Orietta
    Iannazzo, Sergio
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2009, 10 (01) : 33 - 46
  • [8] Clinical considerations for use of insulin degludec/insulin aspart in Japanese patients
    Hirose, Takahisa
    Awata, Takuya
    Yamamoto, Yuiko
    Hemmingsen, Mads Peter
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (01) : 77 - 85
  • [9] Rituximab in the treatment of rheumatoid arthritis patients in Italy: a budget impact analysis
    Benucci, M.
    Iannazzo, S.
    Zaniolo, O.
    Sabadini, L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (05) : 722 - 727
  • [10] BUDGET IMPACT ANALYSIS OF BIPHASIC INSULIN ASPART IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN MALAYSIA: A PUBLIC PAYER PERSPECTIVE
    Tan, S. C.
    Matzen, P.
    Yeo, L. N.
    VALUE IN HEALTH, 2014, 17 (07) : A743 - A743
12345